Literature DB >> 23751831

Adenosquamous carcinoma of the lung: CT, FDG PET, and clinicopathologic findings.

Youkyung Lee1, Jin-Haeng Chung, Sang Eun Kim, Tae Jung Kim, Kyung Won Lee.   

Abstract

PURPOSE: The aim of this study is to evaluate CT, FDG PET, and clinicopathologic features of the adenosquamous carcinoma of the lung (ASC). PATIENTS AND METHODS: Twenty-six patients (M/F = 20:6; mean age, 65.0 years) who underwent surgical resection of ASC were included. The tumors were assessed in terms of size, location, morphologic characteristics, and maximum standardized uptake value (SUVmax) on CT and FDG PET. Proportion of adenocarcinoma was determined. The central and peripheral groups were compared. The differences in disease-free survival among the groups according to the observations were analyzed by Kaplan-Meier test for patients who underwent curative resection (n = 21).
RESULTS: Diameter was 3.8 ± 1.9 cm. Five tumors were located centrally (19.2%) and 21 tumors peripherally (80.8%). Internal low and heterogeneous attenuation was found in all patients. Margins were lobulated in 20 (80%) patients, spiculated in 23 (92%), and ill-defined in 23 (92%). SUVmax was 8.3 ± 3.9. Adenocarcinoma proportion was 33 ± 28%. Central ASC were larger than peripheral ASC (5.7 cm vs. 3.4 cm, P = 0.007). Only SUVmax >6.3 was a poor prognostic factor.
CONCLUSION: ASC was more commonly peripheral than central, and showed internal low and heterogeneous attenuation and possessed lobulated, spiculated, or ill-defined margin on CT. Mean SUVmax of ASC was 8.3 ± 3.9. Central ASC was larger than peripheral ASC. Except for tumor size, central ASC and peripheral ASC showed no significant differences in pathology, FDG PET, and survival. Higher SUVmax was a poor prognostic factor.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 23751831     DOI: 10.1097/RLU.0b013e3182952c2d

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  9 in total

1.  Clinicopathological characteristics and prognosis of patients with adenosquamous lung carcinoma.

Authors:  Ye Guo; Lin Jia; Guo-Guang Shao; Hong-Wei Sun; Xing-Xing Wang; Guan-Jun Wang; Ke-Wei Ma
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-06-14

2.  Prognostic value of combined platelet, fibrinogen, neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in patients with lung adenosquamous cancer.

Authors:  Yu-Qian Wang; Qiong-Jie Zhi; Xin-Yue Wang; Dong-Sheng Yue; Kai Li; Ri-Cheng Jiang
Journal:  Oncol Lett       Date:  2017-07-24       Impact factor: 2.967

3.  Clinical features and prognosis-associated factors of non-small cell lung cancer exhibiting symptoms of bone metastasis at the time of diagnosis.

Authors:  Yi-Fu He; Hui-Qin Luo; Wei Wang; Jian Chen; Yi-Wei Yao; Shan-Bao Cai; Jie He; Ying Yan; Shu-Sheng Wu; Xiao-Xiu Hu; Li-Hong Ke; Jia-Yu Niu; Hui-Min Li; Chu-Shu Ji; Bing Hu
Journal:  Oncol Lett       Date:  2015-03-27       Impact factor: 2.967

4.  CT and PET-CT of a dog with multiple pulmonary adenocarcinoma.

Authors:  Jisun Kim; Seong Young Kwon; Rohani Cena; Seungjo Park; Juyeon Oh; Heejin Oui; Kyoung-Oh Cho; Jung-Joon Min; Jihye Choi
Journal:  J Vet Med Sci       Date:  2013-12-31       Impact factor: 1.267

5.  Adenocarcinomatous-predominant subtype associated with a better prognosis in adenosquamous lung carcinoma.

Authors:  Yangli Liu; Ying Zhu; Lihong Bai; Fengjia Chen; Jue Wang; Yubiao Guo
Journal:  BMC Cancer       Date:  2020-06-05       Impact factor: 4.430

6.  Tumor Location and Survival Outcomes in Lung Adenosquamous Carcinoma: A Propensity Score Matched Analysis.

Authors:  Xinlin Shi; Xiangrong Shao; Yawen Zhang; Feng Wu; Yujian Tao
Journal:  Med Sci Monit       Date:  2020-07-02

Review 7.  Research progress of the clinicopathologic features of lung adenosquamous carcinoma.

Authors:  Jing Wang; Yanling Wang; Mengting Tong; Hongming Pan; Da Li
Journal:  Onco Targets Ther       Date:  2018-10-16       Impact factor: 4.147

8.  A nomogram to predict prognosis of patients with lung adenosquamous carcinoma: a population-based study.

Authors:  Jiaqi Liang; Qihai Sui; Yuansheng Zheng; Guoshu Bi; Zhencong Chen; Ming Li; Yiwei Huang; Tao Lu; Cheng Zhan; Weigang Guo
Journal:  J Thorac Dis       Date:  2020-05       Impact factor: 3.005

Review 9.  Adenosquamous carcinoma of the lung.

Authors:  Chenghui Li; Hongyang Lu
Journal:  Onco Targets Ther       Date:  2018-08-14       Impact factor: 4.147

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.